Search

Semitransparent organic photodetectors (ST‐OPDs) show immense promise for integration into optoelectronic devices, offering adjustable absorption and see‐through functionalities. However, achieving high‐performance ST‐OPDs remains challenging, necessitating a delicate balance of low dark current density, high external quantum efficiency, and optimal visible light transmission. Here, a strategy is presented using anode interfacial materials (AIMs) as the donor and narrow bandgap non‐fullerene acceptors (NFAs) to formulate the donor: acceptor light‐sensitive layer. Critical to the approach is the incorporation of 1,8‐diiodooctane during film processing, enabling the formation of morphology with an NFA molecular crystal network embedded within the donor polymer matrix. This optimized morphology substantially boosted device external quantum efficiency and reduced dark current under reverse bias, yielding a remarkable special detectivity of over 1013 Jones at 840 nm under a bias of −0.1 V. ST‐OPDs are achieved with detectivity surpassing 1012 Jones and notable average visible transmittance of over 50%. These findings highlight the potential of AIM:NFA combinations for high‐efficiency ST‐OPDs by finely controlling morphology through multiple length scales, opening doors for various applications in transparent electronics and beyond. [ABSTRACT FROM AUTHOR]

Stretchable organic photovoltaics (OPVs) are pivotal for advancing conformable electronics, yet achieving both efficient and intrinsically stretchable OPVs remains a significant challenge. The main issue is maintaining electronic and mechanical properties under deformation. Here, a ternary blend system, PTzBI‐oF:PYIT:EVA is presented, incorporating ethylene‐vinyl acetate (EVA) to establish a conjugated and elastomeric dual‐network morphology. The elastomer network dissipates applied stress, preserving the crystalline packing of the conjugated network and enabling improved mechanical stability of charge carrier generation and transport. Specifically, with 15% EVA content, the ternary blend achieved a power conversion efficiency (PCE) of 15.28% in rigid devices and exhibited a crack onset strain of 17.23%. Notably, the stretchable OPVs retained over 80% of their initial PCE under 30% strain. These findings underscore the potential of conjugated and elastomeric dual‐network morphology in developing high‐performance stretchable electronics for various applications. [ABSTRACT FROM AUTHOR]

Objective: To investigate the value of nasal provocation test（NPT） in evaluating the efficacy of allergen immunotherapy（AIT） in patients with dust mite induced allergic rhinitis（AR）. Methods: A total of 83 patients with dust mite induced AR with/without asthma were included. Symptom score（SS）, daily medication score（DMS）, combined symptom and medication score（CSMS）, rhinoconjunctivitis quality of life questionnaire（RQLQ）, NPT and skin prick test（SPT） were assessed before and after 1 year AIT. Results: There were statistical differences in SS（ P <0.000 1）, DMS（ P <0.000 1）, CSMS（ P <0.000 1）, and RQLQ（ P <0.000 1） after 1 year of AIT compared with pre-treatment. The effective rate of CSMS was 73.49%, and the effective rate of NPT was 42.17%. CSMS was consistent with NPT in efficacy assessment（Kappa=0.437, P <0.001）; while in 54 patients with pre-treatment NPT concentrations other than the original concentration, CMSM and NPT showed better consistence（Kappa=0.895, P <0.001）. Among the 48 patients with ineffective NPT assessment in the first year, 25 patients completed the second-year follow-up, and 12 patients（48.00%） showed effective in NPT. However, 10 out of 12 patients（83.33%） with NPT concentration other than original solution pre-treatment showed effective NPT at the second year. Conclusion: NPT can be used as one of the indicators for efficacy evaluation for dust mite induced AR patients, especially for patients with positive NPT induced at lower concentrations before treatment., Competing Interests: The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose., (Copyright© by the Editorial Department of Journal of Clinical Otorhinolaryngology Head and Neck Surgery.)